Figure 2.
The evaluation process for estimating the clinical significance of a drug interaction between drug A and another medicinal product (drug B or HMP) according to FDA (based on Ref. [47]).
The evaluation process for estimating the clinical significance of a drug interaction between drug A and another medicinal product (drug B or HMP) according to FDA (based on Ref. [47]).